Illumina 二代測(cè)序組合試劑盒

Illumina 二代測(cè)序組合試劑盒

"Illumina/TruSight RNA Pan-Cancer Panel Set A/RS-303-1002/1 Ea

" RS-303-1002 Illumina 產(chǎn)品編號(hào)： RS-303-1002美  元  價(jià)： $0.00會(huì)  員  價(jià)： 待定品       牌： Illumina產(chǎn)       地： 美國(guó)公       司： Illumina, Inc.產(chǎn)品分類(lèi)： 其它>其它試劑>芯片公司分類(lèi)： Clinical Research Products "Product Highlights:

The TruSight RNA Pan-Cancer panel provides a comprehensive analysis of the cancer transcriptome. It offers:

Gene expression information, variant calling, and fusion detection with known and novel gene fusion partners

Optimized, low-input protocol for a wide range of sample types including FFPE

A comprehensive view of cancer pathways

Economical RNA sequencing (RNA-Seq) on a desktop sequencer

Highly Sensitive and Economical Targeted Sequencing

The TruSight RNA Pan-Cancer panel enables the quantitative measurement of gene expression as well as the detection of gene fusions with both known and novel gene fusion partners. The panel accommodates as little as 10 ng of total RNA input (or 20 ng from FFPE samples). The focus on a subset of relevant genes enables RNA-Seq with high sensitivity at 8 samples per run on a desktop sequencer, allowing cost-effective access to NGS for any lab.

Intuitive Cloud-based Data Analysis

Analysis can be performed using the RNA-Seq Alignment BaseSpace App. This intuitive tool performs fusion calling andvariant detection, and provides gene expression profiles, offering a comprehensive solution to all cancer researchers.

TruSight RNA Pan-Cancer Sample Datasets

MiSeq Data

10 ng of human reference RNA (UHR), human reference brain RNA (Brain), cell line RNA (MCF7), and 20 ng of breast tumor FFPE RNA (BT) were prepared using the TruSight RNA Pan-Cancer Panel and sequenced on the MiSeq System. Read mapping and fusion calling were performed using the RNA-Seq Alignment App with STAR aligner on BaseSpace Sequence Hub.

View Project

MiniSeq Data

Human reference RNA (HBRR and UHRR), cell line RNA (MCF7), and breast tumor RNA samples were prepared using the TruSight RNA Pan-Cancer panel, and 8 samples were sequenced on the MiniSeq System at a 2x76bp read length with single indexing. The total yield was 4.2 Gb with 96.8% of bases at or above Q30.

Browse the data in BaseSpace Sequence Hub:

View Run

View Project

Access to this data requires a BaseSpace Sequence Hub login.

Register for BaseSpace Sequence Hub

Specifications:

Assay Time 2.5 days

Hands-On Time 11 hours

Input Quantity 10 ng total RNA,20 - 100 ng FFPE RNA

System Compatibility MiSeq,NextSeq 550,MiSeqDx in Research Mode,MiniSeq,NextSeq 500

Method Targeted RNA Sequencing,Sequencing for Cytogenomics

Variant Class Gene Fusions,Somatic Variants,Novel Transcripts,Transcript Variants

Specialized Sample Types FFPE,Low Input

Technology Sequencing

Species Category Human

Cancer Type Pan-Cancer

"

Illumina公司，致力于新一代測(cè)序和芯片技術(shù)的生產(chǎn)與開(kāi)發(fā)，提供產(chǎn)品與應(yīng)用資訊

Illumina公司創(chuàng)立于1998年4月，是遺傳變異和生物學(xué)功能分析領(lǐng)域的優(yōu)秀的產(chǎn)品、技術(shù)和服務(wù)供應(yīng)商。通過(guò)幫助客戶加快實(shí)現(xiàn)生物信息的采集、分析和應(yīng)用，來(lái)改善人類(lèi)健康。

Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products

Illumina公司基因芯片、二代測(cè)序NGS測(cè)序儀及相關(guān)測(cè)序試劑盒等產(chǎn)品

咨詢illumina MiSeq測(cè)序試劑盒等產(chǎn)品歡迎您致電 上海易匯生物科技有限公司：1850 1609 238張經(jīng)理